子宮内避妊器具(IUCD)の欧州市場予測

◆英語タイトル:EUROPE INTRAUTERINE CONTRACEPTIVE DEVICE MARKET FORECAST 2017-2025
◆発行会社/調査会社:Inkwood Research
◆商品コード:INKW711047
◆発行日:2017年10月
◆調査対象地域:欧州
◆産業分野:医療
◆ページ数:112
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD2,000 ⇒換算¥226,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[子宮内避妊器具(IUCD)の欧州市場予測]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

KEY FINDINGSThe Europe intrauterine device market is predicted to reach $1033 million by the end of 2025, rising from $780 million in 2016. This growth can be attributed to the estimated rise in the market’s CAGR by 3.24% over the forecast period of 2017-2025.

MARKET INSIGHTS
According to the Guttmacher Institute, IUCD is an essential part of family planning in the European countries. As per the statics, these devices account for nearly 9%-24% of all contraceptive methods in Europe. The major contributor to the European market is the United Kingdom. The effectiveness of the IUCDs over other devices has increased their popularity among females who are in their twenties. However, the risk of instigating pelvic inflammatory infection (PID) or of an ectopic pregnancy is challenging the market growth.

COMPETITIVE INSIGHTS
Trimedic Supply Network Ltd, Mona Lisa N.V, Bayers Ag, Melbea, Merck & Co, Medisafe Distribution Inc, Pfizer, DKT International, Allergan Plc, HLL Lifecare Limited, Teva Pharmaceutical Industries Limited, Pregna, and Meril Life Sciences Private Limited are few of the established companies in the market.

*** レポート目次(コンテンツ)***

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
4. MARKET DETERMINANTS
4.1. DRIVERS
4.1.1. BETTER TECHNOLOGY IN IUD MAKING THEM SAFER AND EFFECTIVE
4.1.2. LONG TERM USAGE MAKES THEM A POPULAR CHOICE
4.1.3. HEALTH BENEFITS
4.1.4. INCREASE IN GOVERNMENT INITIATIVES TO AVOID UNSOLICITED PREGNANCIES AND ABORTIONS
4.2. MARKET RESTRAINTS
4.2.1. LIMITED ACCESS TO CONTRACEPTIVES AMONGST THE YOUTHS, UNMARRIED PEOPLE AND POORER SEGMENTS OF POPULATIONS
4.2.2. INFERTILITY ISSUES AND OTHER RISKS ASSOCIATED WITH INTRAUTERINE CONTRACEPTIVE DEVICE
4.3. OPPORTUNITIES
4.3.1. OCCURRENCE OF STRONG CONTRACEPTIVE PIPELINE
4.3.2. RATE OF UNINTENDED PREGNANCIES IS VERY HIGH
4.3.3. VERY LOW FAILURE RATE OF IUD AND LOW SIDE EFFECTS
4.4. CHALLENGES
4.4.1. RISK OF INSTIGATING PELVIC INFLAMMATORY INFECTION (PID)
4.4.2. HIGH RISK OF ECTOPIC PREGNANCY
5. MARKET SEGMENTATION
5.1. MARKET BY TYPE 2017-2025
5.1.1. COPPER INTRAUTERINE DEVICE
5.1.2. HORMONAL INTRAUTERINE DEVICE
5.2. MARKET BY PRODUCT 2017-2025
5.2.1. MIRENA
5.2.2. SKYLA MARKET
5.2.3. PARAGARD
5.2.4. OTHER PRODUCTS MARKET
6. KEY ANALYTICAL
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREATS OF SUBSTITUTE PRODUCT
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. VALUE CHAIN ANALYSIS
6.3. LEGAL, POLICY AND REGULATORY FRAMEWORK
6.4. OPPORTUNITY MATRIX
6.5. KEY MARKET PLAYERS
6.6. KEY BUYING CRITERIA
7. GEOGRAPHICAL ANALYSIS
7.1. EUROPE
7.1.1. UNITED KINGDOM
7.1.2. FRANCE
7.1.3. GERMANY
7.1.4. SPAIN
7.1.5. ITALY
7.1.6. REST OF THE EUROPE
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIES
9. COMPANY PROFILES
9.1. COMPETITIVE STRATEGY
9.2. MARKET SHARE ANALYSIS
9.3. ALLERGAN, PLC
9.4. BAYERS AG
9.5. DKT INTERNATIONAL
9.6. EGEMEN INTERNATIONAL
9.7. HLL LIFECARE LIMITED
9.8. KRISHCO MEDICAL PRODUCTS PVT.LTD
9.9. MEDISAFE DISTRIBUTION, INC.
9.10. MERIL LIFE SCIENCES PRIVATE LIMITED
9.11. MERCK & CO.
9.12. MELBEA
9.13. MONA LISA N.V
9.14. OCON MEDICAL LTD
9.15. OKAMOTO INDUSTRIES, INC
9.16. PFIZER
9.17. PREGNA
9.18. SMB CORPORATION
9.19. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
9.20. TRIMEDIC SUPPLY NETWORK LTD
9.21. ZHEJIANG DAJI MEDICAL INSTRUMENTS CO., LTD.

TABLE LIST
TABLE 1 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICE MARKET 2017-2025 ($ MILLION)
TABLE 2 BIRTH CONTROL METHODS AND THEIR FAILURE RATES
TABLE 3 PRODUCT PIPELINE IN INTRAUTERINE CONTRACEPTIVE DEVICES
TABLE 4 IUDS RECOMMENDED FOR SPECIFIC CONDITIONS
TABLE 5 USAGE OF IUD DEVICE IN TERMS OF TYPES
TABLE 6 PROS & CONS OF INTRAUTERINE DEVICES
TABLE 7 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICE (IUD) MARKET BY TYPE 2017-2025 ($ MILLION)
TABLE 8 FDA APPROVED CONTRACEPTIVE METHODS FOR WOMEN
TABLE 9 EUROPE COPPER INTRAUTERINE DEVICE MARKET 2017-2025 ($ MILLION)
TABLE 10 EUROPE HORMONAL INTRAUTERINE DEVICE MARKET 2017-2025 ($ MILLION)
TABLE 11 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICE MARKET BY PRODUCT 2017-2025($ MILLION)
TABLE 12 EUROPE MIRENA MARKET 2017-2025
TABLE 13 EUROPE SKYLA MARKET 2017-2025 ($ MILLION)
TABLE 14 EUROPE PARAGARD MARKET 2017-2025($ MILLION)
TABLE 15 EUROPE OTHER PRODUCT MARKET 2017-2025 ($ MILLION)
TABLE 16 EUROPE INTRAUTERINE CONTRACEPTIVE DEVICE MARKET 2017-2025 ($ MILLION)

FIGURE LIST
FIGURE 1 REASONS FOR NOT PREFERRING CONSUMMABLE CONTRACEPTIVES BY WOMEN
FIGURE 2 EUROPE COPPER INTRAUTERINE DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 3 EUROPE HORMONAL INTRAUTERINE DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 4 EUROPE MIRENA MARKET 2017-2025 ($ MILLION)
FIGURE 5 EUROPE SKYLA MARKET 2017-2025 ($ MILLION)
FIGURE 6 EUROPE PARAGARD MARKET 2017-2025($ MILLION)
FIGURE 7 EUROPE OTHER PRODUCTS MARKET 2017-2025 ($ MILLION)
FIGURE 8 VALUE CHAIN ANALYSIS OF INTRAUTERINE CONTRACEPTIVE MARKET
FIGURE 9 EFFECTIVITY OF VARIOUS IUDS
FIGURE 10 POSSIBLE SIDE EFFECTS OF IUD
FIGURE 11 UNITED KINGDOM INTRAUTERINE CONTRACEPTIVE DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 12 FRANCE INTRAUTERINE CONTRACEPTIVE DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 13 GERMANY INTRAUTERINE CONTRACEPTIVE DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 14 SPAIN INTRAUTERINE CONTRACEPTIVE DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 15 ITALY INTRAUTERINE CONTRACEPTIVE DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 16 REST OF THE EUROPE INTRAUTERINE CONTRACEPTIVE DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 17 GLOBAL IUCD TOP COMPANIES MARKET SHARE 2016 (IN %)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(INKW711047 )"子宮内避妊器具(IUCD)の欧州市場予測" (英文:EUROPE INTRAUTERINE CONTRACEPTIVE DEVICE MARKET FORECAST 2017-2025)はInkwood Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。